Zelin Sheng

1.3k total citations
12 papers, 1.1k citations indexed

About

Zelin Sheng is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Zelin Sheng has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Zelin Sheng's work include Signaling Pathways in Disease (4 papers), Diabetes Treatment and Management (4 papers) and Cardiac Fibrosis and Remodeling (2 papers). Zelin Sheng is often cited by papers focused on Signaling Pathways in Disease (4 papers), Diabetes Treatment and Management (4 papers) and Cardiac Fibrosis and Remodeling (2 papers). Zelin Sheng collaborates with scholars based in United States, China and Germany. Zelin Sheng's co-authors include Kenneth R. Chien, Anning Lin, Shino Nemoto, Ju Chen, Masahiko Hoshijima, Joan Heller Brown, Kirk U. Knowlton, James D. Potter, Diane Pennica and William I. Wood and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular and Cellular Biology.

In The Last Decade

Zelin Sheng

12 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zelin Sheng United States	9	690	469	212	101	89	12	1.1k
Heiko von der Leyen Germany	16	567 0.8×	432 0.9×	71 0.3×	58 0.6×	105 1.2×	38	1.1k
Jennifer Yeung United States	15	472 0.7×	183 0.4×	79 0.4×	43 0.4×	54 0.6×	24	981
M.R. Jirousek United States	10	686 1.0×	112 0.2×	68 0.3×	219 2.2×	56 0.6×	18	1.4k
Lewis J. Watson United States	17	1.0k 1.5×	419 0.9×	59 0.3×	61 0.6×	61 0.7×	22	1.4k
Bo Shan China	18	517 0.7×	145 0.3×	63 0.3×	69 0.7×	52 0.6×	32	1.3k
Lori J. Pease United States	19	992 1.4×	607 1.3×	214 1.0×	304 3.0×	29 0.3×	26	1.5k
Sharon L. Wolda United States	10	1.1k 1.6×	117 0.2×	124 0.6×	41 0.4×	24 0.3×	11	1.2k
Najia Jin United States	18	503 0.7×	194 0.4×	41 0.2×	47 0.5×	53 0.6×	24	1.1k
Kenneth J. Shaw United States	15	619 0.9×	313 0.7×	476 2.2×	29 0.3×	31 0.3×	26	1.4k
Dagfinn Øgreid Norway	23	1.1k 1.6×	79 0.2×	269 1.3×	38 0.4×	61 0.7×	50	1.5k

Countries citing papers authored by Zelin Sheng

Since Specialization

Citations

This map shows the geographic impact of Zelin Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelin Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelin Sheng more than expected).

Fields of papers citing papers by Zelin Sheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelin Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelin Sheng. The network helps show where Zelin Sheng may publish in the future.

Co-authorship network of co-authors of Zelin Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Zelin Sheng. A scholar is included among the top collaborators of Zelin Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelin Sheng. Zelin Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Yu, Jifeng, Haowei Sun, Bin Zhang, et al.. (2023). ZGGS15, a Novel IgG4 Bispecific Monoclonal Antibody Targeting Both LAG-3 and Tigit, Demonstrates Outstanding Anti-Tumor Activity and Can be Used As Monotherapy or in Combination with Anti-PD-1 Antibodies for Cancer Immunotherapy. Blood. 142(Supplement 1). 5764–5764. 1 indexed citations

Zhu, Bing, Alfonso Suárez, Tyler Liban, et al.. (2023). Abstract 6368: Preclinical pharmacology and safety studies of ZG005: an anti-PD-1/TIGIT bispecific mAb in a phase I clinical trial for advanced tumors. Cancer Research. 83(7_Supplement). 6368–6368. 3 indexed citations

Xu, Ge, Jacques Y. Roberge, Jiajia Dong, et al.. (2014). Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 57(4). 1236–1251. 54 indexed citations

Zhang, Wenbin, Ajith Welihinda, Haifeng Ding, et al.. (2011). EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats. Pharmacological Research. 63(4). 284–293. 62 indexed citations

Yan, Feng, Jiajia Dong, Min Xu, et al.. (2010). Conformationally Constrained Spiro C‐Arylglucosides as Potent and Selective Renal Sodium‐Dependent Glucose Co‐transporter 2 (SGLT2) Inhibitors. ChemMedChem. 5(6). 827–831. 14 indexed citations

Yan, Feng, Ge Xu, Ajith Welihinda, et al.. (2009). O-Spiro C-aryl glucosides as novel sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(19). 5632–5635. 20 indexed citations

Yan, Feng, Kun Peng, Ge Xu, et al.. (2009). Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(24). 6877–6881. 28 indexed citations

Nemoto, Shino, Zelin Sheng, & Anning Lin. (1998). Opposing Effects of Jun Kinase and p38 Mitogen-Activated Protein Kinases on Cardiomyocyte Hypertrophy. Molecular and Cellular Biology. 18(6). 3518–3526. 205 indexed citations

Sheng, Zelin, Kirk U. Knowlton, Ju Chen, et al.. (1997). Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway. Journal of Biological Chemistry. 272(9). 5783–5791. 354 indexed citations

10.

Sheng, Zelin, Diane Pennica, William I. Wood, & Kenneth R. Chien. (1996). Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survivals. Development. 122(2). 419–428. 156 indexed citations

11.

Potter, James D., et al.. (1995). A Direct Regulatory Role for Troponin T and a Dual Role for Troponin C in the Ca2+ Regulation of Muscle Contraction. Journal of Biological Chemistry. 270(6). 2557–2562. 151 indexed citations

12.

François, Jean, Zelin Sheng, Danuta Szczȩsna, & James D. Potter. (1995). The Functional Role of the Domains of Troponin-C Investigated with Thrombin Fragments of Troponin-C Reconstituted into Skinned Muscle Fibers. Journal of Biological Chemistry. 270(33). 19287–19293. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact